Join our daily newsletter At The Bell to receive exclusive market insights
- Fiji Kava (FIJ) reports growth from its US branch of business, The Calmer Co, which now accounts for more than half of its global revenue
- The success has been driven by direct-to-consumer sales through Amazon and Danodan
- Since acquiring Danodan earlier in the year, the company has grown the platform, with sales now outperforming Amazon
- Looking ahead, Fiji Kava is planning to develop new product formats to launch Dietary Shots, Gummy lines and Ready to Drink beverages
- Shares are trading 6.67 per cent higher at 3.2 cents each at 12:48 pm AEST.
Fiji Kava (FIJ) has reported growth from its US branch of business, The Calmer Co, which now accounts for more than half of its global revenue.
The success was driven by direct-to-consumer sales through Amazon and Danodan.
The company acquired Danodan at the start of this year to drive its expansion into the US.
It has since grown the platform’s sales revenue by 20 per cent in quarter four to $110,000, with sales now outperforming Amazon.
To further drive US expansion, Fiji Kava appointed retail broker Grass Roots Marketing to grow its distribution over the Pacific Northwest and California regions.
In addition, 11 independent brokers have been appointed to drive national sales, with more to be added to fill geographic gaps.
Looking ahead, the company has planned to develop new product formats to launch Dietary Shots, Gummy lines and Ready to Drink beverages.
CEO Dr Anthony Noble said he was pleased with the growth achieved.
“The strategy for maturing the business into a global, condition-focused natural products company has the US market at its core,” he said.
Shares were trading 6.67 per cent higher at 3.2 cents each at 12:48 pm AEST.
